Cargando…
Risk of Hepatitis B Virus Reactivation in Patients with Resolved Infection on Therapy with Corticosteroids and Conventional Synthesis Immunosuppressants for Kidney Disease: A Single-Center Analysis of 258 Patients
BACKGROUND/AIMS: The risk of hepatitis B virus reactivation in patients with a previously resolved hepatitis B virus infection on therapy with corticosteroids and conventional synthesis immunosuppressants for kidney disease has not been well described. MATERIALS AND METHODS: We performed a retrospec...
Autores principales: | Han, Pingyang, Wang, Ziqiu, Wang, Zhaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Society of Gastroenterology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645278/ https://www.ncbi.nlm.nih.gov/pubmed/37681265 http://dx.doi.org/10.5152/tjg.2023.22511 |
Ejemplares similares
-
Resolved hepatitis B infection in patients receiving immunosuppressive therapy: Monitor versus prophylaxis against viral reactivation
por: Elsebaey, Mohamed A., et al.
Publicado: (2022) -
Hepatitis B virus reactivation with corticosteroid therapy in patients with adrenal insufficiency
por: Hatano, Masako, et al.
Publicado: (2019) -
The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroids
por: Shokri, Somayeh, et al.
Publicado: (2022) -
Effects of rituximab dose on hepatitis B reactivation in patients with resolved infection undergoing immunologic incompatible kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2018) -
Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy
por: Shih, Chih-An, et al.
Publicado: (2021)